Latest Update
Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler...
> read more
Editor's Choice
SAVE THE DATE for Chemspec Europe 2024 Where Fine and Speciality Chemicals Meet Innovation
Chemspec Europe 2024 is confirmed to take place from 19 - 20 June 2024, with Messe Düsseldorf, Germany, as its next stop to showcase the full array of fine and speciality...
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, announced today the grand opening of their state-of-the-art drug...
Chemspec Europe 2023: Record exhibition space and immense visitor growth propel the event to pre-pandemic levels and beyond
The 36th International Exhibition for Fine and Speciality Chemicals concluded last week at the Messe Basel exhibition centre in Switzerland. The largest edition of Chemspec Europe in...
Chemspec Europe 2023: a record-breaking edition reconfirms the importance of the event for the international fine and speciality chemicals industry
Next week, from 24 - 25 May, Chemspec Europe 2023 will open its doors at Messe Basel, Switzerland, to offer a unique marketplace for product sourcing, whilst connecting industry...
Genezen announces presentation at 2023 Annual Meeting of the American Society of Gene and Cell Therapy
Genezen, a leading gene and cell therapy contract development and manufacturing organization (CDMO) announced a poster presentation at the 26th Annual American Society for Gene and...
Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City
VANCOUVER, British Columbia & LONDON, March 22, 2023 – Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development...
Suppliers’ supply chain and continuous manufacturing are the big risk & resilience issues for US CDMOs
Ahead of a CPHI North America panel discussion – Redesigning the Supply Chain – The Road to Increased Resilience – Bikash Chatterjee, CEO of Pharmatech Associates [a USP...
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have entered into a strategic collaboration to identify...
New data suggests investigational oral osteoarthritis drug APPA may have a promising senotherapeutic effect with potential in other diseases of ageing
STEVENAGE, UK, March 20, 2023 – New data* presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in Denver, Colorado (March 17th-20th) suggest that...
Scorpius BioManufacturing Announces the Appointment of Gary Welch as Interim President
San Antonio, TX (USA) – March 21, 2023 –– Scorpius BioManufacturing, a Texas-based biologics contract research and contract development & manufacturing organization (CDMO),...
Chemspec Europe 2023: Key event for the fine and speciality chemicals industry to tackle current challenges in a rapidly changing market
From 24 – 25 May 2023, Chemspec Europe returns to Basel, Switzerland, for the 36th international event dedicated to the fine and speciality chemical industry. The Basel region is one...
Registration now open for the world’s leading life sciences supply chain event
Registration is now open to secure your place at LogiPharma, the world’s leading life sciences supply chain event. Get 5% off using our exclusive discount code: WPF5LP
Experts warn smaller and medium European packaging companies to grow or be acquired ahead of Pharmapack Europe
2023 will see continued packaging consolidation, increased device viscosity capabilities and a more forgiving MDR runway
ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as Chief Executive Officer to Drive Next Stages of Growth
Heilbronn, Germany—ProtaGene GmbH, a leading global contract research organization focused on advanced analytics in biologics and cell and gene therapy, announced today the appointment...
Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom
SHORT HILLS, NJ. June 16, 2022--(BUSINESS WIRE)-- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a late-stage clinical biopharmaceutical company focused on preventing and treating...
Scorpion Biological Services Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer (CEO)
Manhattan, KS (USA) – June 14, 2022 –– Scorpion Biological Services (Scorpion), a biopharmaceutical contract development and manufacturing organization (CDMO) and contract...
Yourway announces new flagship European Depot in Dublin, Ireland
Yourway, the only truly integrated premium courier and clinical packager in the clinical trials supply chain market, announced construction of a new flagship European depot in...
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
Manhattan, KS (USA) – April 26, 2022 –– Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a...
Yourway Adds Additional Capacity for Controlled Ambient Storage in Allentown, PA
Allentown, PA (USA) – April 12, 2022 – Yourway, the only truly integrated premium courier and clinical packager in the clinical trials supply chain market, announced the expansion of...
